U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07715747) titled 'A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors' on July 16.
Brief Summary: The goal of this clinical trial is to evaluate the safety and tolerability of TJ037130 in participants with advanced or metastatic solid tumors, and to determine the Potential Optimal Biological Dose (POBD) of TJ037130 for subsequent investigations.
Study Start Date: Aug. 21
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Metastatic Ovary Cancer
Metastatic Gastric Cancer
Metastatic Endometrial Carcinoma
Intervention:
DRUG: TJ037130
Dose Escalation:TJ03...